Wells Fargo
LUMO

Wells Fargo’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Wells Fargo’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-64,981
Closed -$251K – 7258
2024
Q3 		$251K Sell
64,981
-350,000
-84% -$969K ﹤0.01% 4421
2024
Q2 		$963K Sell
414,981
-570
-0.1% -$1.47K ﹤0.01% 3519
2024
Q1 		$1.17M Sell
415,551
-1,500
-0.4% -$4.45K ﹤0.01% 3348
2023
Q4 		$1.33M Buy
417,051
+502
+0.1% +$1.71K ﹤0.01% 3236
2023
Q3 		$1.37M Buy
416,549
+94,660
+29% +$295K ﹤0.01% 3094
2023
Q2 		$1.06M Buy
321,889
+1
+0% +$4 ﹤0.01% 3432
2023
Q1 		$1.07M Buy
321,888
+3,668
+1% +$12.8K ﹤0.01% 3333
2022
Q4 		$1.15M Sell
318,220
-8,095
-2% -$52.9K ﹤0.01% 3164
2022
Q3 		$2.89M Buy
326,315
+7,739
+2% +$64.3K ﹤0.01% 2428
2022
Q2 		$2.45M Buy
318,576
+374
+0.1% +$2.99K ﹤0.01% 2627
2022
Q1 		$2.99M Buy
318,202
+2,229
+0.7% +$19.9K ﹤0.01% 2907
2021
Q4 		$2.19M Sell
315,973
-1,212
-0.4% -$10.2K ﹤0.01% 3414
2021
Q3 		$3.02M Buy
317,185
+101,227
+47% +$950K ﹤0.01% 3314
2021
Q2 		$2.16M Buy
215,958
+49,873
+30% +$555K ﹤0.01% 3623
2021
Q1 		$1.94M Buy
166,085
+48,425
+41% +$814K ﹤0.01% 3727
2020
Q4 		$4.2M Buy
117,660
+1,268
+1% +$21.9K ﹤0.01% 2910
2020
Q3 		$1.61M Buy
116,392
+4,190
+4% +$62.6K ﹤0.01% 3490
2020
Q2 		$1.85M Buy
112,202
+84,469
+305% +$1.01M ﹤0.01% 3327
2020
Q1 		$235K Buy
27,733
+179
+0.6% +$2.5K ﹤0.01% 4583
2019
Q4 		$628K Sell
27,554
-147
-0.5% -$2.1K ﹤0.01% 4183
2019
Q3 		$396K Sell
27,701
-193
-0.7% -$2.83K ﹤0.01% 4529
2019
Q2 		$372K Sell
27,894
-27,850
-50% -$421K ﹤0.01% 4589
2019
Q1 		$969K Buy
55,744
+63
+0.1% +$939 ﹤0.01% 3901
2018
Q4 		$762K Sell
55,681
-3,102
-5% -$54.6K ﹤0.01% 4051
2018
Q3 		$1.26M Buy
58,783
+746
+1% +$22.7K ﹤0.01% 3784
2018
Q2 		$2.49M Buy
58,037
+12,048
+26% +$552K ﹤0.01% 3286
2018
Q1 		$3M Buy
45,989
+4,469
+11% +$317K ﹤0.01% 3051
2017
Q4 		$3.03M Buy
41,520
+5,027
+14% +$416K ﹤0.01% 3031
2017
Q3 		$3.34M Buy
36,493
+18,072
+98% +$1.39M ﹤0.01% 2864
2017
Q2 		$1.22M Buy
18,421
+318
+2% +$39.4K ﹤0.01% 3583
2017
Q1 		$3.93M Buy
18,103
+522
+3% +$74.6K ﹤0.01% 2634
2016
Q4 		$1.63M Buy
17,581
+839
+5% +$94.5K ﹤0.01% 3315
2016
Q3 		$2.26M Sell
16,742
-12
-0.1% -$1.19K ﹤0.01% 2882
2016
Q2 		$1.7M Buy
16,754
+2,507
+18% +$311K ﹤0.01% 3088
2016
Q1 		$2.33M Buy
14,247
+2,307
+19% +$468K ﹤0.01% 2817
2015
Q4 		$3.91M Sell
11,940
-4,506
-27% -$1.47M ﹤0.01% 2504
2015
Q3 		$5.3M Buy
16,446
+6,365
+63% +$2.8M ﹤0.01% 2286
2015
Q2 		$4.02M Sell
10,081
-873
-8% -$371K ﹤0.01% 2576
2015
Q1 		$5.39M Buy
10,954
+1,897
+21% +$735K ﹤0.01% 2320
2014
Q4 		$3.24M Buy
9,057
+8,445
+1,380% +$2.51M ﹤0.01% 2666
2014
Q3 		$119K Sell
612
-156
-20% -$34.3K ﹤0.01% 4585
2014
Q2 		$183K Sell
768
-476
-38% -$96.8K ﹤0.01% 4411
2014
Q1 		$318K Sell
1,244
-534
-30% -$163K ﹤0.01% 4119
2013
Q4 		$352K Hold
1,778
– – ﹤0.01% 3977
2013
Q3 		$300K Sell
1,778
-501
-22% -$80.6K ﹤0.01% 4005
2013
Q2 		$405K Buy
+2,279
New +$323K ﹤0.01% 3799

Wells Fargo's LUMO Position: Q4 2024 in Review

Wells Fargo sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 64,981 shares — an estimated $251K sold.

Wells Fargo first reported a position in LUMO in Q2 2013 and held it in 46 quarters. The position peaked at $5.39M in Q1 2015. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

  • Wells Fargo reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Wells Fargo sold 64,981 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $251K.
  • Wells Fargo first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 46 quarters.
  • Wells Fargo's Lumos Pharma, Inc. Common Stock position peaked at $5.39M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.